Orelind Erik R MD is categorized under Internal Medicine Practitioners in Chicago, IL and active since 2010.
Orelind Erik R MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Erik Orelind at the company’s single location by writing to 201 East Huron St # 12-105, Chicago, Illinois IL 60611 or by phoning (312) 926-3627. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Orelind Erik R MD |
| Contact Person: | Erik Orelind |
| Address: | 201 East Huron St # 12-105, Chicago, Illinois 60611 |
| Phone Number: | (312) 926-3627 |
| Website Address: | nmpg.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Practitioners |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Orelind Erik R MD was started in 2010 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Erik Orelind for inquiries that concern Orelind Erik R MD by calling the company number (312) 926-3627, as your correspondence is most welcome. Additionally, the physical location of the single location of Orelind Erik R MD can be found at the coordinates 41.894921,-87.622676 as well as the street address 201 East Huron St # 12-105 in Chicago, Illinois 60611.
For its online presence, you may visit Orelind Erik R MD’s website at nmpg.com and engage with its social media outlets through on Twitter and on Facebook.